Last reviewed · How we verify

NCT03378557: PPFx

Periprosthetic Fracture Registry (PPFx)

Recruiting now Last updated 12 September 2025
What this trial tests

trial in Periprosthetic Fractures in 600 participants. Currently enrolling.

Timeline
31 December 2018
Primary endpoint
31 January 2027
31 March 2027

Quick facts

Lead sponsorAO Innovation Translation Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment600
Start date31 December 2018
Primary completion31 January 2027
Estimated completion31 March 2027
Sites13 locations across Colombia, Belgium, Germany, Switzerland, United States, Spain

Conditions studied

Sponsor

AO Innovation Translation Center

Who can join

18 and older, any sex, with Periprosthetic Fractures or Periprosthetic Fracture Around Prosthetic Joint Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty. A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Fracture fixation versus revision arthroplasty in Vancouver type B2 and B3 periprosthetic femoral fractures: a systematic review.
    Stoffel K, Blauth M, Joeris A, Blumenthal A, et al · · 2020 · cited 58× · PMID 32086558 · DOI 10.1007/s00402-020-03332-7
  2. Periprosthetic Femoral Fractures-Beyond B2.
    Uzoigwe CE, Watts AT, Briggs P, Symes T. · · 2024 · cited 2× · PMID 39110721 · DOI 10.5435/jaaosglobal-d-23-00135

Verify or expand the search:

Other recruiting trials for Periprosthetic Fractures

Currently open trials in the same condition.

Other AO Innovation Translation Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03378557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing